Multiplikator forward rega marang pendapatan Lantheus Corp (LNTH)

Lantheus Corp (LNTH) - logo korporat

A stable staff of radiologists and the motivation of R&D personnel create a foundation for the growth of Lantheus Holdings, Inc. (LNTH). However, reliance on imports from Asia and Europe leaves raw material logistics vulnerable to sanctions. The forward P/S metric captures these risks, where the parameter value equals 2.60. Meanwhile, global conflicts and the short shelf life of drugs limit the company's expansion into international markets.

Lantheus - Rega forward marang dodolan LNTH (periode 04.07.2022 - 17.11.2026)

Lantheus Holdings, Inc. (LNTH) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Pambiji fundamental perusahaan:Lantheus Corp LNTH
Produk asli Lantheus Corp

Lantheus Holdings, Inc. (LNTH) controls a monopoly segment of radiopharmaceuticals, where the unique logistics of Pylarify and FDA protection guarantee exceptional clinic loyalty. This forward price-to-sales ratio chart correlates the company's market value with expected sales, allowing investors to conduct a real-time assessment of business stability and promptly identify either an undervalued asset or rising liquidity risks.